Lower respiratory tract levels of CCL5 are associated with high viral loads of SARS-CoV-2 (Pérez-García et al., 2022), and with inflammation, atherosclerosis complications of COVID-19 (Das and Podder, 2021). The gene discussed is CCL5; the disease is atherosclerosis.